Literature DB >> 26458339

Knowledge of serotype prevalence & burden of invasive pneumococcal disease: A prerequisite to vaccine introduction in the country.

Reba Kanungo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26458339      PMCID： PMC4669858          DOI： 10.4103/0971-5916.166528

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  16 in total

1.  Throat carriage of pneumococci in healthy school children in the Union Territory of Pondicherry.

Authors:  R Kanungo; D d'Lima; B Rajalakshmi; M K Natarajan; S Badrinath
Journal:  Indian J Med Res       Date:  2000-09       Impact factor: 2.375

Review 2.  Why it is still important that countries know the burden of pneumococcal disease.

Authors:  Rosa Prato; Silvio Tafuri; Francesca Fortunato; Domenico Martinelli
Journal:  Hum Vaccin       Date:  2010-11-01

3.  Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Authors:  Ronald J Stanek; Mary B Maher; Nancy B Norton; Maurice A Mufson
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

4.  Pneumococcal nasopharyngeal colonization in young South Indian infants.

Authors:  C L Coles; R Kanungo; L Rahmathullah; R D Thulasiraj; J Katz; M Santosham; J M Tielsch
Journal:  Pediatr Infect Dis J       Date:  2001-03       Impact factor: 2.129

5.  Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN)

Authors: 
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

6.  Serotype distribution & antimicrobial resistance in Streptococcus pneumoniae causing invasive & other infections in south India.

Authors:  R Kanungo; B Rajalakshmi
Journal:  Indian J Med Res       Date:  2001-10       Impact factor: 2.375

7.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

8.  Nasopharyngeal carriage of resistant pneumococci in young South Indian infants.

Authors:  C L Coles; L Rahmathullah; R Kanungo; R D Thulasiraj; J Katz; M Santosham; J M Tielsch
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

Review 9.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Authors:  D Bogaert; R De Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

10.  Serotype distribution & sensitivity pattern of nasopharyngeal colonizing Streptococcus pneumoniae among rural children of eastern India.

Authors:  Utpala Devi; Archana Ayyagari; Kangjam Rekha Devi; Kanwar Narain; Dilip Kumar Patgiri; Arunima Sharma; Jagadish Mahanta
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375
View more
  2 in total

1.  Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India.

Authors:  Itamar Megiddo; Eili Klein; Ramanan Laxminarayan
Journal:  BMJ Glob Health       Date:  2018-05-09

2.  Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial.

Authors:  Bhagirath B Solanki; Christine Juergens; Manojkumar B Chopada; Pravin Supe; Vani Sundaraiyer; Natacha Le Dren-Narayanin; Mark W Cutler; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.